Discover 1,440 paid clinical trials in Quebec. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 1,440
Early Detection of Treatment Failure in Metastatic Colorectal Cancer Patients
for
Colorectal Cancer Metastatic
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 18+
Code: NCT05068531
Recruiting
Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis
for
Nonalcoholic Fatty Liver Disease (NAFLD),
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 18+
Code: NCT03572465
Recruiting
Optimal Brain Oxygenation in Neurologic Intensive Care Unit : The NeurO2 Study
Increased Early Pain Relief by Adding Vertebroplasty to SBRT
for
Spine Metastases, Radiation Therapy, Pain
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 18+
Code: NCT05317026
Recruiting
Monitoring of Metabolic Adverse Events of Second Generation Antipsychotics in a Naive Pediatric Population
for
Adverse Drug Event
Location: Montreal
Sponsor: St. Justine's Hospital
Sex: All
Age: 0 - 18
Code: NCT04395326
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
for
Biliary Tract Cancer
Location: Halifax, White Plains NY, Montreal, Towson MD,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06467357
Phase3, Recruiting
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
for
Melanoma, Cutaneous Malignant
Location: Boston MA, New Haven CT, New York NY, Morristown NJ,
Sponsor: Immatics US, Inc.
Sex: All
Age: 18+
Code: NCT06743126
Phase3, Recruiting
Visual Outcomes of Vivity in Patients With Well Controlled Glaucoma
for
Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT),
Location: Montreal
Sponsor: Maisonneuve-Rosemont Hospital
Sex: All
Age: 18+
Code: NCT05075226
Recruiting
Longitudinal Prospective Natural History Study of Retinopathy in Zellweger Spectrum Disorder
for
Zellweger Spectrum Disorder
Location: Montreal, Rochester NY, Edmonton
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: All
Age: 0+
Code: NCT06190626
Recruiting
Ancef Dosage in Knee Arthroplasty : Tourniquet Clinical Trial
for
Infections Joint Prosthetic
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: All
Age: 18 - 70+
Code: NCT05604157
Recruiting
Validation of Continuous Monitoring of Vital Signs in Children With a Connected Patch
for
Vital Signs
Location: Montreal
Sponsor: St. Justine's Hospital
Sex: All
Age: 0 - 18
Code: NCT04627766
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for
Colorectal Neoplasms
Location: Shirley NY, New Haven CT, Mineola NY, The Bronx NY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06662786
Phase3, Recruiting
Impact of PEG Bowel Preparation on Gut Microbiome Composition Recovery
for
Cancer, Healthy Participants
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 18 - 70
Code: NCT06831539
Phase1, Recruiting
Exploring the Association of Sport Nutrition Knowledge and Self-reported Physique Concerns on Eating Behaviours in Elite Athletes Receiving Individualized Sport Nutrition Support
for
Behavior
Location: Montreal
Sponsor: McGill University
Sex: All
Age: 18 - 40
Code: NCT05709639
Recruiting
BoStOn SCientific Rhythm MAnagemenT REgiStry
for
Cardiac Disease
Location: Quebec
Sponsor: Boston Scientific Corporation
Sex: All
Age: 0+
Code: NCT04823663
Recruiting
Impact of Administration of Esmolol on Nociception Level-guided Control of Nociception.